Market Place
Sourcing Support
Angle PLC Announces Notice of Results
05 Sep 2025 //
PHARMAWEB
Angle Partners with Myriad Genetics
20 Aug 2025 //
PHARMAWEB
Angle PLC: Parsortix Facilitates Cancer Progression Study
08 Jul 2025 //
ACCESSWIRE
ANGLE PLC Announces Result of 2025 Annual General Meeting
30 Jun 2025 //
ACCESSWIRE
Angle plc Announces Novel Discoveries Into the Biology of Cancer
10 Jun 2025 //
ACCESSWIRE
Angle PLC Announces Posting of Annual Report and Notice of AGM
09 Jun 2025 //
ACCESSWIRE
Angle PLC Announces Board Changes
06 Jun 2025 //
ACCESSWIRE
Angle PLC Announces Preliminary Results
28 May 2025 //
ACCESSWIRE
Angle PLC Announces Notice of Results
23 May 2025 //
ACCESSWIRE
Angle PLC Announces Issue of LTIP Options and Share Options
21 Mar 2025 //
ACCESSWIRE
Angle PLC Announces Results of Eisai Phase 2 pilot study
21 Mar 2025 //
ACCESSWIRE
Angle Announces Analysis of CTC-DNA & ctDNA using Illumina assay
28 Jan 2025 //
ACCESSWIRE
Angle Announces Parsortix Used in Research Paper from ETH Zurich
24 Jan 2025 //
ACCESSWIRE
Angle PLC Announces Trading Update
23 Jan 2025 //
ACCESSWIRE
Angle PLC Announces HER2 Presentation at SABCS
13 Dec 2024 //
ACCESSWIRE
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
15 Nov 2024 //
ACCESSWIRE
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
15 Nov 2024 //
ACCESSWIRE
ANGLE presents two posters at EACR
13 Nov 2024 //
ACCESSWIRE
Angle PLC Announces Parsortix enriched ctDNA in NSCLC patients
11 Nov 2024 //
ACCESSWIRE
Angle PLC Announces Exclusive agreement for DNA NGS panel
20 Sep 2024 //
ACCESSWIRE
Angle PLC Announces Agreement with Recursion Pharmaceuticals
19 Sep 2024 //
ACCESSWIRE
Angle PLC Announces Notice of Interim Results and Webcast
17 Sep 2024 //
ACCESSWIRE
Angle PLC - Data Supporting FDA Approval Published in Journal
22 Aug 2024 //
ACCESSWIRE
Angle PLC Announces Standard Form for Notification of Major Holdings
12 Jul 2024 //
ACCESSWIRE
Angle PLC Announces Result of 2024 Annual General Meeting
11 Jul 2024 //
ACCESSWIRE
Angle PLC Announces Posting Of 2023 Annual Report And Notice Of AGM
18 Jun 2024 //
ACCESSWIRE
Angle PLC Announces Parsortix and Assays being Showcased at EACR 2024
12 Jun 2024 //
ACCESSWIRE
Angle PLC Announces Preliminary Results
05 Jun 2024 //
ACCESSWIRE
Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix
15 May 2024 //
ACCESSWIRE
Angle PLC Announces New Commercial Agreement with Large Pharma
03 May 2024 //
ACCESSWIRE
ANGLE shares jump 30% on AstraZeneca tie-up
24 Apr 2024 //
PROACTIVEINVESTOR
Angle PLC Announces New Commercial Agreement with AstraZeneca
24 Apr 2024 //
ACCESSWIRE
Angle Gets US, EU Patents For CellKeep Slide Screening
22 Apr 2024 //
ACCESSWIRE
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
08 Apr 2024 //
ACCESSWIRE
Angle PLC Announces Parsortix at European Breast Cancer Conference
22 Mar 2024 //
ACCESSWIRE
